Riskpilot← Back to searchSign inGet full accessWinmed A/S
A/SActiveCVR 39195186Strandvejen 100Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20171 employeeswww.winmed.dk
Revenue 2024
DKK 4,4M
+165% vs 2023
EBITDA margin
61.0%
+597% vs 2023
Equity ratio
-17.9%
Financial strength
Net profit 2024
DKK 1,2M
+128% vs 2023
| Revenue | DKK 4,4M | +165% |
| EBITDA | DKK 2,7M | +597% |
| Net profit | DKK 1,2M | +128% |
| Total assets | DKK 25,7M | -2% |
| Equity | DKK -4,6M | +21% |
| Employees | 1 | — |
Legal name
Winmed A/S
CVR number
39195186
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. december 2017
Share capital
DKK 400.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er distribution og salg af lægemidler samt efter ledelsens skøn hermed beslægtet virksomhed.
Address
Strandvejen 100
Phone
+4533371022
Email
info@winmed.dk
Website
www.winmed.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2.862 | 696 | 323 | 1.656 | 4.389 |
| Staff expenses | -48 | -68 | -122 | -431 | -523 |
| EBITDA | 2.813 | 628 | 201 | -539 | 2.678 |
| Depreciation & amort. | -283 | -1.697 | -1.697 | -1.697 | -1.697 |
| EBIT | 2.531 | -1.069 | -1.497 | -2.237 | 981 |
| Net financials | -37 | -13 | -172 | -2.063 | 209 |
| Profit before tax | 2.494 | -1.083 | -1.669 | -4.300 | 1.190 |
| Tax | 538 | -190 | -0 | -0 | -0 |
| Net profit | 1.955 | -893 | -1.669 | -4.300 | 1.190 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13.546 | 12.080 | 34.430 | 26.319 | 25.683 |
| Equity | 1.939 | 993 | -726 | -5.798 | -4.608 |
| Long-term debt | 8.487 | 9.026 | 8.487 | 8.487 | 8.487 |
| Short-term debt | 2.916 | 2.061 | 26.669 | 23.630 | 21.805 |
| Total debt | 11.402 | 11.087 | 35.155 | 32.117 | 30.292 |
EBITDA margin
61.0%
This company
15.8%
Market median
+286% vs market
20202024
Equity ratio
-17.9%
This company
38.2%
Market median
-147% vs market
20202024
Return on equity
118976100.0%
This company
18.4%
Market median
+646609139% vs market
20202024
Net profit margin
27.1%
This company
8.1%
Market median
+235% vs market
20202024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20202024
Debt / equity
6.57×
This company
0.62×
Market median
-960% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
WL Founder | Founder | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Chairman | 2022 – 2023 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Winmed A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Winzor Ltd. | Founder | 0 companies |
| Christian Vinding Thomsen | Chairman | 0 companies |
| Elena Zorina Zorina | Board of Directors | 0 companies |
| Sebastian Rungby | Chairman | 0 companies |
| Elena Zorina | Board of Directors | 0 companies |